NsGene was spun off from NeuroSearch A/S in December 1999 and was funded by venture capital and a loan from Vækstfonden (a Danish governmental growth fund). The investors that each holds more than 5 percent ownership, and which jointly hold more than 90 percent of the share capital can be seen below.
